Hormonal Changes in Menopause and Orexin-A Action by Giovanni Messina, Andrea Viggiano, Vincenzo De Luca, Antonietta Messina, Sergio Chieffi, Marcellino Monda

“…Orexins are hypothalamic neuropeptides recently discovered, involved in the regulation of feeding behaviour, sleep-wakefulness rhythm, and neuroendocrine homeostasis. …”
Get full text

Can serum orexin levels be used as a marker in childhood epilepsy? by Mutluay Arslan, Canan Üstün, Ayşe Nur Coşkun, Hasan Çelik, Hacı Nadir Yalçın, Eda Karaismailoğlu, Erdim Sertoğlu, Bülent Ünay

Subjects: Get full text

Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia by Andrew H. Han, Caroline R. Burroughs, Evan P. Falgoust, Jamal Hasoon, Grace Hunt, Juyeon Kakazu, Tim Lee, Adam M. Kaye, Alan D. Kaye, Latha Ganti

“…While there are many existing treatments such as benzodiazepines, melatonin agonists, TCAs, and atypical antipsychotics used to target various receptors involved in normal induction and maintenance of sleep, Suvorexant is an antagonist that specifically targets orexin receptors. Recent clinical studies suggest that Suvorexant is both clinically safe and effective. …”
Get full text

Learned phenotypes emerge during social stress modifying hippocampal orexin receptor gene expression by Jazmine D. W. Yaeger, Justin K. Achua, Clarissa D. Booth, Delan Khalid, Megan M. John, Leighton J. Ledesma, Trent L. Greschke, Ashley M. Potter, Chase B. Howe, Kevin T. Krupp, Justin P. Smith, Patrick J. Ronan, Cliff H. Summers

Subjects: Get full text

Deficiency of orexin receptor type 1 in dopaminergic neurons increases novelty-induced locomotion and exploration by Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, Anna Lena Cremer, Heiko Backes, Peter Kloppenburg, Anne Christine Hausen

Subjects: “…orexin…”
Get full text

Reduction of orexin-expressing neurons and a unique sleep phenotype in the Tg-SwDI mouse model of Alzheimer’s disease by Yan Wu, Narayan R. Bhat, Meng Liu

Subjects: Get full text

食欲素 B 增强视皮层第 2/3 层传入到第 6b 层锥体神经细胞的突触传递 by 黄梦瑶, 童昕

Subjects: Get full text

Influence of sleep on seizures and interictal epileptiform discharges in epilepsy by Jun-Sang Sunwoo

Subjects: Get full text

Effect of Orexin-A on Cortisol Secretion in H295R Cells via p70S6K/4EBP1 Signaling Pathway by Xiaocen Chang, Yuyan Zhao, Lei Guo

“…Orexin-A is a neuropeptide that orchestrates diverse central and peripheral processes. …”
Get full text

Role of Hypothalamus in Acupuncture’s Effects by Ryan Bae, Hyung Kyu Kim, Baoji Lu, Jing Ma, Juping Xing, Hee Young Kim

Subjects: Get full text

食欲素 B 增强外膝体纤维投射至视皮层第 6b 层锥体细胞的突触传递 by 童昕, 黄梦瑶

“…【目的】探究食欲素B（Orexin B）调控外膝体（LGN）纤维投射至视皮层（visual cortex，VC）第6层b亚层（L6b）中的食欲素B敏感神经元（Orexin敏感神经元）的突触传递作用。…”
Get full text

Daridorexant for the Treatment of Insomnia by Christopher L Robinson, Rajesh Supra, Evan Downs, Saurabh Kataria, Katelyn Parker, Alan D. Kaye, Omar Viswanath, Ivan Urits

“…Pharmacotherapy for insomnia falls into four classes based on mechanism of action: benzodiazepine receptor agonists (BZRAs), histamine receptor antagonists, melatonin receptor agonists, and dual orexin receptor antagonists (DORAs). # Recent Findings Daridorexant is a dual orexin type 1 and types 2 (OX~1~ and OX~2~) receptor antagonist that was recently approved by the US FDA for the treatment of adults suffering from insomnia. …”
Get full text

Changes in Ghrelin-Related Factors in Gastroesophageal Reflux Disease in Rats by Miwa Nahata, Yayoi Saegusa, Yumi Harada, Naoko Tsuchiya, Tomohisa Hattori, Hiroshi Takeda

“…However, melanin-concentrating hormone (MCH) and prepro-orexin mRNA expression in the hypothalamus of GERD rats was similar to that in sham-operated rats. …”
Get full text

Evaluation of the effects of a team‐based systematic prevention and management program for postoperative orthopedic older patients: A retrospective cohort study by Fumitake Yamaguchi, Chie Inomata, Naoki Yoshinaga, Hirotake Sawada, Kazuko Shimamoto, Ayaka Haruta‐Tsukamoto

“…Results After the DELTA program's implementation, a significant decrease in benzodiazepine receptor agonist prescriptions (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.29–0.53) and an increase in prescriptions of either melatonin receptor agonists or dual orexin receptor antagonists (OR, 3.83; 95% CI, 2.49–5.88) were observed. …”
Get full text